GEXVal to Present at BIO Asia-Taiwan 2024 Investment Summit

GEXVal Inc.
July 12, 2024

GEXVal to Present at BIO Asia-Taiwan 2024 Investment Summit

GEXVal Inc. will be presenting at the 2024 Investment Summit, a concurrent event of BIO ASIA-Taiwan, scheduled from July 24th to 28th, 2024.

BIO Asia-Taiwan is widely recognized as a gathering place for global biotechnology industry leaders and investors to explore the latest technological innovations and business opportunities. The Investment Summit, in particular, serves as a crucial platform where 48 carefully selected companies from around the world deliver presentations to globally active venture capital firms. This summit acts as a catalyst, connecting companies with innovative technologies and business models to potential investors, thereby fostering industry growth.

GEXVal Inc. has successfully passed the rigorous selection process for this event. President and CEO Juran Kato is scheduled to present our unique technology and business model to deliver innovative and life-changing medicines with patients and families who live with rare and untreatable diseases.

Event Details
Bio Asia Taiwan 2024 Investment Summit (Pre-registration required)
：BIO Asia–Taiwan 2024 亞洲生技大會 (bioasiataiwan.com)
Pitch Date and Time：July 25,2024 10:50 pm – 12:10 pm
Category：Therapeutics & Pharmaceuticals Session 4
Venue       ：TaiNEX2 7F

For further information:
Head of Corporate office
Atsushi Sugizaki
info@gexval.com